Zentalis Pharma Stock (NASDAQ: ZNTL) stock price, news, charts, stock research, profile.
You can purchase shares of Zentalis Pharma (NASDAQ:ZNTL) through any online brokerage.
Other companies in Zentalis Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Monopar Therapeutics (NASDAQ:MNPR), Larimar Therapeutics (NASDAQ:LRMR), Genfit (NASDAQ:GNFT) and Lexeo Therapeutics (NASDAQ:LXEO).
Zentalis Pharma has a consensus price target of $18.10.
The stock price for Zentalis Pharma (NASDAQ: ZNTL) is $2.28 last updated January 17, 2025 at 7:55 PM EST.
There are no upcoming dividends for Zentalis Pharma.
Zentalis Pharma’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
There is no upcoming split for Zentalis Pharma.
Zentalis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.